Consent of Independent Auditors


We consent to the incorporation by reference in the Registration Statements
summarized below, of our report dated February 22, 2001, except for Note 11, as
to which the date is March 13, 2001, with respect to the consolidated financial
statements of NaPro BioTherapeutics, Inc. included in the Annual Report (Form
10-K) for the year ended December 31, 2000.

o    Form S-8 (No. 333-05561) pertaining to the 1993 Stock Option Plan and the
     1994 Long-Term Performance Incentive Plan of NaPro BioTherapeutics, Inc.;

o    Form S-8 (No. 333-75551) pertaining to the 1994 Long-Term Performance
     Incentive Plan and the 1998 Stock Incentive Plan of NaPro BioTherapeutics,
     Inc.;

o    Form S-8 (No. 333-52008) pertaining to the 1994 Long-Term Performance
     Incentive Plan and the 1998 Stock Incentive Plan of NaPro BioTherapeutics,
     Inc.;

o    Form S-3 (No. 33-95522) and related Prospectus pertaining to 1,375,000
     shares of common stock of NaPro BioTherapeutics, Inc.;

o    Form S-3 (No. 333-29477) and related Prospectus pertaining to 1,600,000
     shares of common stock of NaPro BioTherapeutics, Inc.;

o    Form S-3 (No. 333-42419) and related Prospectus pertaining to 1,000,000
     shares of common stock of NaPro BioTherapeutics, Inc.;

o    Form S-3 (No. 33-78016) and related Prospectus pertaining to 360,000 shares
     of common stock, 180,000 warrants, and 1,005,000 other shares of common
     stock by selling stockholders of NaPro BioTherapeutics, Inc.; and

o    Form S-3 (No. 333-51070) and related Prospectus pertaining to the
     registration of 2,213,334 shares of common stock of NaPro BioTherapeutics,
     Inc.


Denver, Colorado
March 30, 2001